Avenue Therapeutics Inc (ATXI)
$2.72
Performance
- $2.60$3.05$2.72
4.41%
Downside
Day's Volatility :14.82%
Upside
10.89%
- $2.72$85.50$2.72
0.0%
Downside
52 Weeks Volatility :96.82%
Upside
96.82%
Returns
| Period | Avenue Therapeutics Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -53.71% | 0.0% |
6 Months | -74.49% | 0.0% |
1 Year | -96.46% | 0.0% |
3 Years | -99.86% | -20.2% |
Highlights
Market Capitalization | 3.7M |
Book Value | $4.81 |
Earnings Per Share (EPS) | 12.67 |
PE Ratio | 0.31 |
PEG Ratio | 0.0 |
Wall Street Target Price | 12.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -125.66% |
Return On Equity TTM | -535.1% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | 12.67 |
Quarterly Earnings Growth YOY | -0.76 |
EPS Estimate Current Year | -5.74 |
EPS Estimate Next Year | -3.33 |
EPS Estimate Current Quarter | -9.0 |
EPS Estimate Next Quarter | -7.5 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 341.18%
Technicals Summary
Sell
Neutral
Buy
Avenue Therapeutics Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Avenue Therapeutics Inc | -21.8% | -74.49% | -96.46% | -99.86% | -99.96% |
 Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
 Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
 Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
 Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Avenue Therapeutics Inc | 0.31 | 0.31 | 0.0 | -5.74 | -5.35 | -1.26 | NA | 4.81 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Avenue Therapeutics Inc | Buy | $3.7M | -99.96% | 0.31 | 0.0% |
Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Insights on Avenue Therapeutics Inc
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 158.1%
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 286.4%
Institutional Holdings
Geode Capital Management, LLC
0.07%Vanguard Group Inc
0.07%State Street Corporation
0.04%Millennium Management LLC
0.04%TWO SIGMA SECURITIES, LLC
0.04%HRT FINANCIAL LLC
0.04%
Company Information
avenue therapeutics, inc. (nasdaq: atxi), a fortress biotech (nasdaq: fbio) company, is a specialty pharmaceutical company focused on the development and commercialization of intravenous (iv) tramadol for the management of moderate to moderately severe postoperative pain. iv tramadol may fill a gap in the acute pain market between iv acetaminophen/nsaids and iv conventional narcotics. avenue is currently evaluating iv tramadol in a pivotal phase 3 program for the management of postoperative pain.
Organization | Avenue Therapeutics Inc |
Employees | 3 |
CEO | Dr. Alexandra MacLean M.D. |
Industry | Health Technology |
Discover More
A Spac I Acquisition Corp
$2.72
-5.23%
Keyarch Acquisition Corp
$2.72
-5.23%
Connexa Sports Technologies Inc
$2.72
-5.23%
Us Value Etf
$2.72
-5.23%
First Wave Biopharma Inc
$2.72
-5.23%
Global X Msci Next Emerging
$2.72
-5.23%
Fat Projects Acquisition Corp
$2.72
-5.23%
Capital Link Global Fintech
$2.72
-5.23%
Applied Uv Inc
$2.72
-5.23%